A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used. (PICCNUT)
A Monocenter Prospective Study to Evaluate the Efficacy of Peripherally Inserted Central Catheter to Tunnelled Central Catheter With Cuff in Home Parenteral Nutrition for Long-term Used: the PICCnut Study.
Home parenteral nutrition (HPN) is the reference treatment for anatomic or fonctionnal chronic intestinal failure. Nutritionnal catheter must follow two rules: low infection rate and be able to preserve the permeability of the central vein. Today, in europeen guidelines, two types of central devices are recommended: tunnelled central catheter with cuff and implanted ports. However, their insertion is not without risk. Since many years, we have seen a new generation of catheter - peripherally inserted central catheter (PICC line)- which have many advantage over other central catheter. ESPEN guidelines accept the use of PICC line in short and moderate-term for HPN, but no prospective study have look for long-term used in HPN.
The objective of our study is to evaluate in a prospective randomised monocenter study the no-inferiority of PICC line to tunnelled central catheter with cuff for serious catheter related-complications such as infection and thrombophlebitis for patient on HPN over 1 month of duration. The secondary objectives are to: evaluate the number of patients with at least one serious complications related in 1000 days of used, the rate of minors and majors complications, number of catheter inserted, the satisfaction of patients and doctors.
The study is held in CHU Nice and will be proposed to hospitalized patients who will need HPN. After consent, patients will be randomized to receive PICC Line (group A) of nutritional central catheter with cuff (group B). Echography of vessels will be held at the beginning, 3 months and 12 months. Follow-up will be conduct at regular interval (month 0-1-3-6-9-12). The duration of follow-up will be of 12 months and the global duration of the study will be 36 months. One major complication will conduct to withdrawal of the study. There will be 55 patients in each group.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, Frankreich, 06200
- CHU de Nice
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- > 18 years-old
- Patients managed by CHU Nice for home parenteral nutrition
- Expected to have over 1 month of parenteral nutrition
- Signed consent
- Affiliation to Securite Social
Exclusion criteria
- Patient with nutritional catheter before inclusion
- Pregnancy or breastfeeding
- Evolutive pathology with life expectancy < 12 months
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Group B
After consent, patients will be randomised to PICC Line (group A) or tunnelled nutritional central catheter with cuff (group B).
Duration of inclusion will be 24 months.
After randomisation, patients will have catheter inserted by a competent radiologist following an echography.
Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications.
|
After consent, patients will be randomised to PICC Line (group A) or tunnelled nutritional central catheter with cuff (group B).
Duration of inclusion will be 24 months.
After randomisation, patients will have catheter inserted by a competent radiologist following an echography.
Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications.
After that, vessels echography will be systematically repeated at 3 months and 12 months for thrombosis research.
Follow-up visit will be held at 1,3,6,9 and 12 months.
At every step, major and minor complications will be noted by the investigators.
|
|
Experimental: Group A
PICC Line (group A) : patients will have catheter inserted by a competent radiologist following an echography.
Radiologist will have to answer a questionnaire and doctors will note any catheter-related complications.
|
Vessels echography will be systematically repeated at 3 months and 12 months for thrombosis research.
Follow-up visit will be held at 1,3,6,9 and 12 months.
At every step, major and minor complications will be noted by the investigators.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
major complications
Zeitfenster: 12 months
|
Statically significative difference between rate of incidence of major complications (infection and/or thrombosis related to catheter) during the 12 months follow-up.
|
12 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Delay
Zeitfenster: 12 months
|
Delay in days between insertion and first major complications
|
12 months
|
|
Questionnaire
Zeitfenster: 12 months
|
Questionnaire to evaluate catheter insertion by radiologist (satisfaction and complications). Satisfaction questionnaire to patients at every visit |
12 months
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: HEBUTERNE Xavier, PhD, CHU de Nice, Hôpital Archet, Pôle Digestif, 151 route de saint-antoine de ginestière 06200 Nice
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 12-PP-02
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Chronisches Darmversagen
-
Israa Ahmed abdelhalimNoch keine RekrutierungRate of Carbapenemase Intestinal Carrier Inside ICU